$SOTK

SONO TEK CORP

3
2
6

No SEC Form 4 filings for $SOTK in the last 30 days.

See all $SOTK insider activity →
High

Earnings call transcript: Sono-Tek misses Q2 2027 estimates as shares fall 11%

Sono-Tek Corp. reported Q2 2027 earnings below expectations, with EPS of $0.02 (vs. $0.04 estimate) and revenue of $5.23M (vs. $5.56M estimate). Shares fell 11.1% premarket. Despite revenue growth and margin expansion, management expects flat to modest growth for the rest of fiscal 2027. The company's backlog grew to $10.79M, driven by large medical and alternative-energy orders.

Sono-Tek stock falls 14% on second quarter earnings, revenue miss

Sono-Tek (SOTK) reported Q2 fiscal 2027 earnings and revenue below estimates, with shares down 14.47% premarket. Revenue was $5.23M, up 1% YoY, while EPS was $0.02, missing estimates by $0.02. Medical sector sales surged 209% to $3.11M. The company maintained full-year guidance for flat to modest growth, citing order timing. Backlog increased 23% to $9.51M.

SOTK sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 11 news stories mentioning SOTK (SONO TEK CORP). Coverage has skewed bearish: 3 bullish, 2 neutral, and 6 bearish.

Recent SOTK coverage spans earnings, financial news and market movers.

What's driving SOTK

  • Sono-Tek Corp. reported Q2 2027 earnings below expectations, with EPS of $0.02 (vs. $0.04 estimate) and revenue of $5.23M (vs. $5.56M estimate). Shares fell 11.1% premarket. Despite revenue growth and margin expansion, management expects flat to modest growth for the rest of fiscal 2027. The company's backlog grew to $10.79M, driven by large medical and alternative-energy orders.

    investing.com · Oct 14, 2026

  • Earnings preview; no new guidance disclosed.

    benzinga.com · Oct 14, 2026

  • Earnings miss and lower guidance pressure the stock lower.

    investing.com · Oct 14, 2026

  • Strong medical‑sector sales and higher‑value systems drove earnings beat, but guidance remains unchanged.

    SEC EDGAR 8-K · Oct 14, 2026

  • The recent surge lacks fundamental support and could face selling pressure.

    zacks.com · Oct 1, 2026

AlphAI scores every news story that mentions SOTK with an AI model for sentiment and relevance, and aggregates insider trades from SONO TEK CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $SOTK

Score
High

Earnings call transcript: Sono-Tek misses Q2 2027 estimates as shares fall 11%

Sono-Tek Corp. reported Q2 2027 earnings below expectations, with EPS of $0.02 (vs. $0.04 estimate) and revenue of $5.23M (vs. $5.56M estimate). Shares fell 11.1% premarket. Despite revenue growth and margin expansion, management expects flat to modest growth for the rest of fiscal 2027. The company's backlog grew to $10.79M, driven by large medical and alternative-energy orders.

$SOTKHigh

Sono-Tek stock falls 14% on second quarter earnings, revenue miss

Sono-Tek (SOTK) reported Q2 fiscal 2027 earnings and revenue below estimates, with shares down 14.47% premarket. Revenue was $5.23M, up 1% YoY, while EPS was $0.02, missing estimates by $0.02. Medical sector sales surged 209% to $3.11M. The company maintained full-year guidance for flat to modest growth, citing order timing. Backlog increased 23% to $9.51M.

$SOTKMed

Sono-Tek Reports Fiscal Second Quarter and First Half 2027 Results Driven by Strong Medical Sector and Higher Value Production Systems

SONO TEK CORP (SOTK) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Sono-Tek Reports Fiscal Second Quarter and First Half 2027 Results Driven by Strong Medical Sector and Higher Value Production Systems First Half Revenue Increased 6% to $10.9 Million; Gross Margin Expanded to 55%; Operating Income Increased 41%; Medical Market Sales

$SOTKLow

SonoTek (SOTK) Moves 18.5% Higher: Will This Strength Last?

Sono-Tek (SOTK) shares rose 18.5% to $5.9 on high volume. The company benefits from increased demand for its ultrasonic coating systems in clean energy. Q2 earnings are expected at $0.05 per share, up 66.7% YoY, with revenues at $5.68M, up 10.1% YoY. The consensus EPS estimate has not changed in 30 days. GlobalFoundries (GFS) also mentioned, up 0.1% to $47.92, with a 9% monthly return.

Related tickers